Julia Wang joined BeiGene in June 2020 and serves as Chief Financial Officer. Ms. Wang brings extensive global finance experience across biotech, pharmaceutical, medical device, diagnostic testing, and consumer products. She previously served as Senior Vice President, Global Business Finance, Corporate Finance and Corporate FP&A at Alexion Pharmaceuticals, and prior to that worked in various leadership roles at Quest Diagnostics. Ms. Wang previously worked for more than five years at Johnson & Johnson leading finance at several operating companies, including Xian-Janssen Pharmaceutical, J&J’s pharmaceutical business in China.

Ms. Wang holds an MBA from Fuqua School of Business at Duke University and a B.A. in British language and literature from Shandong Normal University.